Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Labcorp Holdings ( ($LH) ) has issued an announcement. On October 8, 2025, Labcorp Holdings Inc. announced that its Board of Directors declared a ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Labcorp Holdings is set to release its third-quarter earnings this month, and analysts anticipate solid double-digit growth ...

Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in ...

On Tuesday, the College of Healthcare Information Management Executives (CHIME) held an event to launcha $1 millionglobal ...

Quest Diagnostics can benefit from continued demand for specific diagnostic testing across a broad range of clinical areas.

The Monongalia County Health Department offers affordable sexual health resources, free STI testing, partner notification and ...

Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.

In the assessment of 12-month price targets, analysts unveil insights for Labcorp Hldgs, presenting an average target of $297.5, a high estimate of $310.00, and a low estimate of $282.00. This current ...

These Subscription, Authentication and Mobile Products Terms and Conditions govern your use of the subscription, authentication and mobile products offered by the NFL from time to time. These ...